News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
787,731 Results
Type
Article (79788)
Company Profile (483)
Press Release (707460)
Section
Business (211237)
Career Advice (3735)
Deals (37924)
Drug Delivery (124)
Drug Development (89655)
Employer Resources (180)
FDA (17713)
Job Trends (16408)
News (368645)
Policy (36989)
Tag
Academia (2971)
Alliances (53496)
Alzheimer's disease (1436)
Approvals (17667)
Artificial intelligence (250)
Bankruptcy (375)
Best Places to Work (12529)
Biotechnology (358)
Breast cancer (250)
Cancer (1919)
Cardiovascular disease (155)
Career advice (3171)
CAR-T (149)
Cell therapy (426)
Clinical research (71788)
Collaboration (758)
Compensation (394)
COVID-19 (2838)
C-suite (192)
Data (1750)
Diabetes (244)
Diagnostics (6755)
Earnings (80915)
Employer resources (157)
Events (122693)
Executive appointments (625)
FDA (18726)
Funding (676)
Gene therapy (301)
GLP-1 (785)
Government (5035)
Healthcare (20667)
Infectious disease (2971)
Inflammatory bowel disease (139)
Interviews (730)
IPO (17406)
Job creations (4371)
Job search strategy (2593)
Layoffs (518)
Legal (8792)
Lung cancer (280)
Manufacturing (270)
Medical device (14301)
Medtech (14306)
Mergers & acquisitions (20930)
Metabolic disorders (657)
Neuroscience (1920)
NextGen: Class of 2025 (7489)
Non-profit (5057)
Northern California (2253)
Obesity (363)
Opinion (264)
Patents (186)
People (62648)
Phase I (22182)
Phase II (31213)
Phase III (23462)
Pipeline (835)
Postmarket research (3390)
Preclinical (9923)
Radiopharmaceuticals (264)
Rare diseases (374)
Real estate (6722)
Regulatory (25141)
Research institute (2637)
Resumes & cover letters (593)
Southern California (1939)
Startups (3938)
United States (20419)
Vaccines (728)
Weight loss (271)
Date
Today (233)
Last 7 days (916)
Last 30 days (3110)
Last 365 days (36677)
2025 (5990)
2024 (37494)
2023 (42221)
2022 (53570)
2021 (58357)
2020 (57270)
2019 (50892)
2018 (38737)
2017 (36142)
2016 (36563)
2015 (42367)
2014 (36474)
2013 (32888)
2012 (34780)
2011 (34849)
2010 (34598)
Location
Africa (1152)
Arizona (212)
Asia (46510)
Australia (8230)
California (5216)
Canada (1784)
China (441)
Colorado (238)
Connecticut (260)
Europe (107370)
Florida (761)
Georgia (177)
Illinois (541)
Indiana (288)
Maryland (825)
Massachusetts (4071)
Michigan (219)
Minnesota (368)
New Jersey (1482)
New York (1483)
North Carolina (991)
Northern California (2253)
Ohio (188)
Pennsylvania (1163)
South America (1517)
Southern California (1939)
Texas (755)
Utah (163)
Washington State (510)
787,731 Results for "american association for the study of liver diseases".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
November 18, 2024
·
4 min read
Approvals
Mirum Establishes Liver Expertise With First FDA Nod for ‘Very Rare’ Disease
Ctexli’s approval further entrenches Mirum as a leader in rare liver diseases, alongside its cornerstone product Livmarli and upcoming drug volixibat.
February 24, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
October 15, 2024
·
2 min read
Press Releases
Vivet Therapeutics to Present Key Findings on its Gene Therapy Program for Cerebrotendinous Xanthomatosis at the American Association for the Study of Liver Diseases Annual Meeting
November 14, 2024
·
7 min read
News
Gilead to Present Latest Research Across Key Liver Disease Indication at the American Association for the Study of Liver Disease (AASLD) Meeting 2024
October 22, 2024
·
16 min read
Press Releases
Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases
November 13, 2024
·
2 min read
Press Releases
Rectify Pharmaceuticals to Present New Preclinical Data at The American Association for the Study of Liver Diseases Annual Meeting
October 17, 2024
·
2 min read
Press Releases
American Liver Foundation and the United States Department of Veterans Affairs and Veteran Health Administration Partner to help Veterans at risk or living with Liver Disease
January 23, 2025
·
5 min read
Biotech Beach
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
Gyre Therapeutics announced the presentation of a poster at the American Association for the Study of Liver Diseases’ Annual Liver Meeting, November 10-14, 2023, in Boston, Massachusetts.
November 13, 2023
·
5 min read
Press Releases
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting
October 30, 2024
·
11 min read
1 of 78,774
Next
